177 related articles for article (PubMed ID: 29050954)
1. The TRENDY multi-center randomized trial on hepatocellular carcinoma - Trial QA including automated treatment planning and benchmark-case results.
Habraken SJM; Sharfo AWM; Buijsen J; Verbakel WFAR; Haasbeek CJA; Öllers MC; Westerveld H; van Wieringen N; Reerink O; Seravalli E; Braam PM; Wendling M; Lacornerie T; Mirabel X; Weytjens R; Depuydt L; Tanadini-Lang S; Riesterer O; Haustermans K; Depuydt T; Dwarkasing RS; Willemssen FEJA; Heijmen BJM; Méndez Romero A
Radiother Oncol; 2017 Dec; 125(3):507-513. PubMed ID: 29050954
[TBL] [Abstract][Full Text] [Related]
2. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
[TBL] [Abstract][Full Text] [Related]
3. Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study.
Eriguchi T; Takeda A; Oku Y; Ishikura S; Kimura T; Ozawa S; Nakashima T; Matsuo Y; Nakamura M; Matsumoto Y; Yamazaki S; Sanuki N; Ito Y
Radiat Oncol; 2013 May; 8():113. PubMed ID: 23641879
[TBL] [Abstract][Full Text] [Related]
4. Automated VMAT planning for postoperative adjuvant treatment of advanced gastric cancer.
Sharfo AWM; Stieler F; Kupfer O; Heijmen BJM; Dirkx MLP; Breedveld S; Wenz F; Lohr F; Boda-Heggemann J; Buergy D
Radiat Oncol; 2018 Apr; 13(1):74. PubMed ID: 29685166
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results.
Lambrecht M; Clementel E; Sonke JJ; Nestle U; Adebahr S; Guckenberger M; Andratschke N; Weber DC; Verheij M; Hurkmans CW
Radiother Oncol; 2019 Mar; 132():63-69. PubMed ID: 30825971
[TBL] [Abstract][Full Text] [Related]
6. Quality assurance for a multicenter Phase II study of stereotactic ablative radiotherapy for hepatocellular carcinoma ≤5 cm: a planning dummy run.
Bae SH; Kim MS; Jang WI; Kim KB; Cho KH; Kim WC; Lee CY; Kim ES; Choi CW; Chang AR; Jo S; Kim JY
Jpn J Clin Oncol; 2017 Jun; 47(6):535-542. PubMed ID: 28419246
[TBL] [Abstract][Full Text] [Related]
7. Inverse treatment planning for spinal robotic radiosurgery: an international multi-institutional benchmark trial.
Blanck O; Wang L; Baus W; Grimm J; Lacornerie T; Nilsson J; Luchkovskyi S; Cano IP; Shou Z; Ayadi M; Treuer H; Viard R; Siebert FA; Chan MK; Hildebrandt G; Dunst J; Imhoff D; Wurster S; Wolff R; Romanelli P; Lartigau E; Semrau R; Soltys SG; Schweikard A
J Appl Clin Med Phys; 2016 May; 17(3):313-330. PubMed ID: 27167291
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy.
Wills L; Maggs R; Lewis G; Jones G; Nixon L; Staffurth J; Crosby T;
Radiat Oncol; 2017 Nov; 12(1):179. PubMed ID: 29141663
[TBL] [Abstract][Full Text] [Related]
9. Full automation of spinal stereotactic radiosurgery and stereotactic body radiation therapy treatment planning using Varian Eclipse scripting.
Teruel JR; Malin M; Liu EK; McCarthy A; Hu K; Cooper BT; Sulman EP; Silverman JS; Barbee D
J Appl Clin Med Phys; 2020 Oct; 21(10):122-131. PubMed ID: 32965754
[TBL] [Abstract][Full Text] [Related]
10. Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours.
Hoffmann L; Persson GF; Nygård L; Nielsen TB; Borrisova S; Gaard-Petersen F; Josipovic M; Khalil AA; Kjeldsen R; Knap MM; Kristiansen C; Møller DS; Ottosson W; Sand H; Thing R; Pøhl M; Schytte T
Radiother Oncol; 2022 Jun; 171():53-61. PubMed ID: 35421513
[TBL] [Abstract][Full Text] [Related]
11. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
[TBL] [Abstract][Full Text] [Related]
12. Fully automated, multi-criterial planning for Volumetric Modulated Arc Therapy - An international multi-center validation for prostate cancer.
Heijmen B; Voet P; Fransen D; Penninkhof J; Milder M; Akhiat H; Bonomo P; Casati M; Georg D; Goldner G; Henry A; Lilley J; Lohr F; Marrazzo L; Pallotta S; Pellegrini R; Seppenwoolde Y; Simontacchi G; Steil V; Stieler F; Wilson S; Breedveld S
Radiother Oncol; 2018 Aug; 128(2):343-348. PubMed ID: 29970259
[TBL] [Abstract][Full Text] [Related]
13. Online dosimetric evaluation of larynx SBRT: A pilot study to assess the necessity of adaptive replanning.
Mao W; Rozario T; Lu W; Gu X; Yan Y; Jia X; Sumer B; Schwartz DL
J Appl Clin Med Phys; 2017 Jan; 18(1):157-163. PubMed ID: 28291932
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
15. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
[TBL] [Abstract][Full Text] [Related]
16. Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.
Moustakis C; Blanck O; Ebrahimi Tazehmahalleh F; Ka Heng Chan M; Ernst I; Krieger T; Duma MN; Oechsner M; Ganswindt U; Heinz C; Alheit H; Blank H; Nestle U; Wiehle R; Kornhuber C; Ostheimer C; Petersen C; Pollul G; Baus W; Altenstein G; Beckers E; Jurianz K; Sterzing F; Kretschmer M; Seegenschmiedt H; Maass T; Droege S; Wolf U; Schoeffler J; Haverkamp U; Eich HT; Guckenberger M
Strahlenther Onkol; 2017 Oct; 193(10):780-790. PubMed ID: 28567503
[TBL] [Abstract][Full Text] [Related]
17. A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients.
Khalladi N; Dejean C; Bosset M; Pointreau Y; Kinj R; Racadot S; Castelli J; Huguet F; Renard S; Guihard S; Tao Y; Rouvier JM; Johnson A; Bourhis J; Xu Shan S; Thariat J
Cancer Radiother; 2021 Dec; 25(8):755-762. PubMed ID: 34565664
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.
Oechsner M; Odersky L; Berndt J; Combs SE; Wilkens JJ; Duma MN
Radiat Oncol; 2015 Dec; 10():249. PubMed ID: 26626865
[TBL] [Abstract][Full Text] [Related]
19. Planning Benchmark Study for Stereotactic Body Radiation Therapy of Liver Metastases: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery.
Moustakis C; Blanck O; Chan MKH; Boda-Heggemann J; Andratschke N; Duma MN; Albers D; Bäumer C; Fehr R; Körber SA; Schmidhalter D; Alraun M; Baus WW; Beckers E; Dierl M; Droege S; Ebrahimi Tazehmahalleh F; Fleckenstein J; Guckenberger M; Heinz C; Henkenberens C; Hennig A; Köhn J; Kornhuber C; Krieger T; Loutfi-Krauss B; Mayr M; Oechsner M; Pfeiler T; Pollul G; Schöffler J; Tümmler H; Ullm C; Walke M; Weigel R; Wertman M; Wiehle R; Wiezorek T; Wilke L; Wolf U; Eich HT; Schmitt D
Int J Radiat Oncol Biol Phys; 2022 May; 113(1):214-227. PubMed ID: 35074434
[TBL] [Abstract][Full Text] [Related]
20. [Internal target volume definition using four-dimensional CT and dosimetric evaluation for hepatocellular carcinoma].
Xi M; Liu MZ; Deng XW; Liu H; Huang XY; Zhang L; Li QQ; Hu YH; Cai L; Cui NJ
Ai Zheng; 2007 Jan; 26(1):1-8. PubMed ID: 17222359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
